Full range of Medical Affairs services including pre-launch readiness, marketing material sign-off, certification, medical information, late-phase studies, and post-marketing surveillance.
- Medical Information, Literature reviews
- Advisory Boards, Investigators Meetings & Steering Committees, Key Opinion Leaders (KOL) interactions
- Strategic planning, budget management, business development: drugs acquisitions, out-licensing, divestments, due diligence medical assessment – final signatory
- Market Access projects include – Companion Diagnostics (CDx): pharmacoeconomic dossiers presentation to National Health Funds & Health Technology Agencies (HTA), HTA publications
- Pharmacoeconomic and outcome research (phase III-IV, PRO & HEOR, Real World Evidence (RWE), employing the Electronic Health Records (EHR) to Accelerated Approval (AA) pathway.